Evidence map›Paper›PMID 42051703›Full record

SynthesisFrontiers in medicine2026

Detection rate of [

Domenico Albano, Slavko Tasevski, Ramin Sadeghi, Giorgio Treglia, Alessio Rizzo

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Efficacy and safety of [Frontiers in medicine · 2026
    Pooled it
  2. Head-to-head comparison ofEJNMMI research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Domenico AlbanoDepartment of Nuclear Medicine, University of Brescia, Brescia, Italy.
Slavko TasevskiUniversity Institute for Positron Emission Tomography, Skopje, North Macedonia.
Ramin SadeghiNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Giorgio TregliaDivision of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Alessio RizzoDepartment of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/objective: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) remains a fundamental diagnostic tool for Prostate cancer (PCa), yet its use is frequently constrained by the high costs and infrastructure requirements of PET imaging. [ Methods: A comprehensive literature search of the PubMed/MEDLINE, Scopus, and Cochrane libraries was performed to extract relevant published articles about the DR of [ Results: Twenty-three studies ( Conclusions: In conclusion, our analysis showed that [

Indexed as

meta-analysisnuclear medicineprostate cancerPSMASPECT/CT

Identifiers

PMID42051703
PMCPMC13111079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.